FDG-PET/CT as a useful tool for disease activity assessment in large vessel vasculitis in childhood

Pediatr Rheumatol Online J. 2025 May 9;23(1):48. doi: 10.1186/s12969-025-01091-6.

Tobias Krickau^{1

2

3}, Armin Atzinger⁴, Joerg Juengert^{5

6

7}, Juergen Rech^{6

7

8}, Oliver Rompel⁹, André Hoerning^{5

6

7}

¹ Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestraße 15, 91054, Erlangen, Germany. tobias.krickau@uk-erlangen.de.
² Centre for Rare Diseases Erlangen (ZSEER), Erlangen, Germany. tobias.krickau@uk-erlangen.de.
³ DZI (Deutsches Zentrum für Immuntherapie), Erlangen, Germany. tobias.krickau@uk-erlangen.de.
⁴ Department of Nuclear Medicine, University Hospital Erlangen, Erlangen, Germany.
⁵ Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestraße 15, 91054, Erlangen, Germany.
⁶ Centre for Rare Diseases Erlangen (ZSEER), Erlangen, Germany.
⁷ DZI (Deutsches Zentrum für Immuntherapie), Erlangen, Germany.
⁸ Department of Rheumatology and Immunology, University Hospital Erlangen, Erlangen, Germany.
⁹ Department of Radiology, University Hospital Erlangen, Erlangen, Germany.

No abstract available

Keywords: FDG-PET/CT; Inflammation of large vessels; MRI; Takayasu arteriitis in children; Tocilizumab.

Publication types